A further presentation during the same symposium at AD/PD 2025 focused on how MRI methods could be accelerated to improve ...

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

Encouraging interim results have supported Roche’s decision to move trontinemab into a pivotal Phase III programme.